GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Regencell Bioscience Holdings Ltd (NAS:RGC) » Definitions » Pretax Margin %

Regencell Bioscience Holdings (Regencell Bioscience Holdings) Pretax Margin % : % (As of Jun. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Regencell Bioscience Holdings Pretax Margin %?

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Regencell Bioscience Holdings's Pre-Tax Income for the six months ended in Jun. 2023 was $-2.75 Mil. Regencell Bioscience Holdings's Revenue for the six months ended in Jun. 2023 was $0.00 Mil. Therefore, Regencell Bioscience Holdings's pretax margin for the quarter that ended in Jun. 2023 was %.

The historical rank and industry rank for Regencell Bioscience Holdings's Pretax Margin % or its related term are showing as below:


RGC's Pretax Margin % is not ranked *
in the Drug Manufacturers industry.
Industry Median: 4.135
* Ranked among companies with meaningful Pretax Margin % only.

Regencell Bioscience Holdings Pretax Margin % Historical Data

The historical data trend for Regencell Bioscience Holdings's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Regencell Bioscience Holdings Pretax Margin % Chart

Regencell Bioscience Holdings Annual Data
Trend Jun19 Jun20 Jun21 Jun22 Jun23
Pretax Margin %
- - - - -

Regencell Bioscience Holdings Semi-Annual Data
Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
Pretax Margin % Get a 7-Day Free Trial Premium Member Only - - - - -

Competitive Comparison of Regencell Bioscience Holdings's Pretax Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Regencell Bioscience Holdings's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Regencell Bioscience Holdings's Pretax Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Regencell Bioscience Holdings's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where Regencell Bioscience Holdings's Pretax Margin % falls into.



Regencell Bioscience Holdings Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

Regencell Bioscience Holdings's Pretax Margin for the fiscal year that ended in Jun. 2023 is calculated as

Pretax Margin=Pre-Tax Income (A: Jun. 2023 )/Revenue (A: Jun. 2023 )
=-6.062/0
= %

Regencell Bioscience Holdings's Pretax Margin for the quarter that ended in Jun. 2023 is calculated as

Pretax Margin=Pre-Tax Income (Q: Jun. 2023 )/Revenue (Q: Jun. 2023 )
=-2.747/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Regencell Bioscience Holdings  (NAS:RGC) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.


Regencell Bioscience Holdings Pretax Margin % Related Terms

Thank you for viewing the detailed overview of Regencell Bioscience Holdings's Pretax Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Regencell Bioscience Holdings (Regencell Bioscience Holdings) Business Description

Traded in Other Exchanges
N/A
Address
29 Leighton Road, 9/F Chinachem Leighton Plaza, Causeway Bay, Hong Kong, HKG
Regencell Bioscience Holdings Ltd is engaged in the research, development and commercialization of traditional Chinese medicine. The medicines are used for the treatment of neurocognitive disorders and degeneration.

Regencell Bioscience Holdings (Regencell Bioscience Holdings) Headlines

From GuruFocus